The advent of adenovirus: Gene therapy for cardiovascular disease

Circulation

Volumn 88, Issue 4, 1993, Pages 1937-1942

  Schneider, Michael D ^a   French, Brent A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Atherosclerosis; Current perspectives; Genetics; Muscles

Indexed keywords

DYSTROPHIN;

ADENOVIRUS; ATHEROSCLEROSIS; BECKER MUSCULAR DYSTROPHY; CARDIOVASCULAR DISEASE; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENE TRANSFER; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMAL; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; GENE THERAPY; HUMAN; MUSCULAR DYSTROPHY, ANIMAL; RECURRENCE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027504782     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.4.1937     Document Type: Review

References (56)

1. Anderson WF. Human gene therapy. Science. 1992;256:808-813.
2. Miller AD. Human gene therapy comes of age. Nature. 1992;357: 455-460.
3. Ginsberg HS, ed. The Adenoviruses. New York: Plenum Press; 1984.
4. Gurwith MJ, Horwith GS, Impellizzeri CA, Davis AR, Lubeck MD, Hung PP. Current use and future directions of adenovirus vaccine. Semin Respir Infect. 1989;4:299-303.
5. Haj-Ahmad Y, Graham FL. Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J Virol. 1986;57:267-274.
6. Karlsson S, Van Doren K, Schweiger SG, Nienhuis AW, Gluzmna Y. Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors. EMBO J. 1986;5:2377-2385.
7. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Gene Transfer and Expression Protocols. Clifton, NJ: Humana; 1991:109-127.
8. Graham FL, Smiley J, Russel WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59-72.
9. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992;90:626-630.
10. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A. 1993;90:2812-2816.
11. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq JP, Crystal RG. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1992;1:372-378.
12. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in LDL receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. In press.
13. Kopfler WP, Willard M, Betz T, Willard JE, Gerard RD, Meidell RS. Adenovirus-mediated human apolipoprotein A1 gene transfer increases circulating HDL cholesterol in mice. Clin Res. 1993; 41:211A.
14. Gussoni E, Pavlath GK, M. LA, Sharma KR, Miller RG, Steinman L, Blau HM. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 1992;356:435-438.
15. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 1991;352: 815-818.
16. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel JL. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci U S A. 1992;89:2581-2584.
17. Wolff JA, W. MR, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465-1468.
18. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M, Kahn A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 1993;361:647-650.
19. Matsumura K, Lee CC, Caskey CT, Campbell KP. Restoration of dystrophin-associated proteins in skeletal muscle of mdx mice transgenic for dystrophin gene. FEBS Lett. 1993;320:276-280.
20. Cox GA, Cole NM, Phelps SA, Faulkner JA, Chamberlain JS. Overexpression of dystrophin in mdx mice eliminates dystrophic symptoms without toxicity. J Cell Physiol. 1993;17E:242.
21. Muller DW, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol. 1992;19:418-432.
22. Wolinsky H, Thung S-N. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol. 1990;15:475-481.
23. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990; 249:1285-1288.
24. Lim CS, Chapman GD, Gammon RS, Muhlestein JB, Bauman RP, Stack RS, Swain JL. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation. 1991;83: 2007-2011.
25. Chapman GD, Lim CS, Gammon RS, Culp SC, Desper JS, Bauman RP, Swain JL, Stack RS. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res. 1992;71:27-33.
26. Mazur W, Ali MN, Finnigan JP, Raizner AE, French BA. Influenza hemagglutinin enhancement of lipofectin-mediated gene transfer into human, porcine and canine coronary smooth muscle cells in vitro: comparison with recombinant adenovirus. Restenosis Summit V, May 20-21, Cleveland, Ohio, 1993.
27. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal, uninjured blood vessels using replication deficient recombination adenovirus vectors. Circ Res. 1993;72:1132-1138.
28. Willard JE, Jessen ME, Gerard RD, Meidell RS. Recombinant adenovirus is an efficient vector for in vivo gene transfer and can be preferentially directed at vascular endothelium or smooth muscle cells. Circulation. 1992;86(suppl I):I-473.
29. Barr E, Tripathy SK, Kozarsky K, Wilson J, Carroll JD, Shroff SG, Leiden JM. PCGT, catheter-based gene transfer into the heart using replication-deficient recombinant adenoviruses. J Cell Biochem. 1993;17D:195.
30. Mazur W, Ali M-N, Finnigan JP, Cromeens DM, Raizner AE, French BA. Efficient in vivo gene transfer into porcine coronary arteries using recombinant adenoviral vectors. J Cell Biochem. 1993;17E:226.
31. Ali MN, Mazur W, Rodgers GP, French BA, Raizner AE. Recombinant adenovirus-mediated in vivo gene transfer into porcine coronary arteries: time course of reporter gene expression. Restenosis Summit V, May 20-21, Cleveland, Ohio, 1993.
32. Nabel EG, Yang ZY, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor-B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
33. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature. 1993;362:844-846.
34. Kitsis RN, Buttrick PM, Mcnally EM, Kaplan ML, Leinwand LA. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci U S A. 1991;88:4138-4142.
35. Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 1990;82:2217-2221.
36. Acsadi G, Jiao SS, Jani A, Duke D, Williams P, Chong W, Wolff JA. Direct gene transfer and expression into rat heart in vivo. New Biol. 1991;3:71-81.
37. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A. 1990;87: 9568-9572.
38. Williams RS, A. JS, Riedy M, DeVit MJ, McElligott SG, Sanford JC. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A. 1991;88: 2726-2730.
39. Fenjves ES, Gordon DA, Pershing LK, Williams DL, Taichman LB. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc Natl Acad Sci U S A. 1989;86:8803-8807.
40. Palmer TD, Rosman GJ, Osborne WR, Miller AD. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A. 1991;88:1330-1334.
41. Ponder KP, Gupta S, Leland F, Darlington G, Finegold M, DeMayo J, Ledley FD, Chowdhury JR, Woo SL. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A. 1991;88: 1217-1221.
42. Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci U S A. 1991;88:3155-3159.
43. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 1991;254:1509-1512.
44. Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 1991;254:1507-1509.
45. Barr E, Lin H, Bolling SF, Engelmann GL, Leiden JM. Induction of angiogenesis following in vivo gene transfer into myocardium. Circulation. 1991;84(suppl II):II-420.
46. Kirshenbaum LA, MacLellan WR, Mazur W, French BA, Schneider MD. Highly efficient gene transfer to adult rat ventricular myocytes by recombinant adenovirus. J Clin Invest 1993; 92:381-387.
47. Leinwand LA, Kitsis RN, Buttrick P, Sindhqani R, Ismail-Beigi F. Gene transfer into the adult mammalian heart in vivo. J Cell Physiol. 1993;17D:193.
48. Barr E, Boiling S, Parmacek MS, Kozasrsky K, Wilson J, Tripathy S, Englemann G, Leiden JM. Gene transfer into cardiac and skeletal myocytes in vivo. J Cell Biochem. 1993;17D:192.
49. Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH. Receptor-mediated gene delivery in vivo: partial correction of genetic analbuminemia in Nagase rats. J Biol Chem. 1991;266: 14338-14342.
50. Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci U S A. 1991;88:8850-8854.
51. Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A. 1992;89:6094-6098.
52. Kay MA, Li Q, Finegold M, Stratford-Perricaudet LD, Woo SLC. Recombinant adenoviral vectors for hepatic gene therapy. J Cell Biochem. 1993;17E:207.
53. Jiao S, Williams P, Berg RK, Hodgeman BA, Liu L, Repetto G, Wolff JA. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Genet Therap. 1992;3:21-33.
54. Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 1993;28:67-90.
55. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 1991;10:3941-3950.
56. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, Pavriani A, Lecocq J-P, Crystal RG. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992;68:143-155.